Novartis teams up with Oxford researchers to crunch big data into clinical insights
Since Vas Narasimhan’s Day 1 as CEO of Novartis, he has championed data science and digital technologies as a key priority at the pharma giant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
